Covid-19 Vaccine

Photo: The Financial Express

Govt Planning To Offer COVID Vaccines At Pvt Hospitals For Rs 250/Jab

The Health Ministry is supposedly planning to offer COVID-19 vaccines at private hospitals for inoculating people above 60 and over 45 having comorbidities from March 1. As a part of the upcoming vaccination drive, the vaccines will be available at Rs 250/dose in 20,000 hospitals. Initially, while only Serum Institue of India's Covisheld will be available at private hospitals, around 1,500 NABH and NBE accredited hospitals have sought… read-more

Sat, 27 Feb 2021 - 06:45 PM / by Nikita Thakur

Tags: Covid Vaccination, Covid-19 Vaccine, Covishield vaccine, Serum Institute of India

covax delivery at Ghana's airport

Photo: CBS News

Ghana 1st Country To Receive COVAX Vaccines; Gets 6L Jabs From India

West-African country Ghana became the first country to obtain vaccines under the COVAX initiative as it welcomed 6,00,000 doses of the AstraZeneca vaccine by Serum Institute of India on February 24. Delivered by UNICEF, the vaccines reached Ghana’s Kotoka International Airport as part of the initial wave of COVID-19 vaccines that COVAX is granting to 92 low/middle-income nations. Reportedly, Ghana’s will commence its phased vaccination drive… read-more

Wed, 24 Feb 2021 - 08:59 PM / by Ashly Ann Varghese

Tags: Ghana, COVAX, UNICEF, Serum Institute of India, AstraZeneca, Covid -19, vaccine

Courtesy: The Hindu

Serum Institute Of India

Photo: The Print

S. Africa Asks Serum Institute To Take Back AstraZeneca COVID Vaccine

The South African government has requested the Serum Institute of India to withdraw one million shots of its COVID-19 vaccine 'AstraZeneca'. The country has reportedly stopped the rollout of the vaccine after finding it provided only mild to moderate protection against the African variant of coronavirus. Moreover, South Africa will now use Johnson & Johnson’s vaccine for its health workers. Recently, on February 15, the WHO gave emergency… read-more

Wed, 17 Feb 2021 - 10:40 AM / by Nikita Thakur

Tags: Covid Vaccine, Serum Institute of India, South Africa, AstraZeneca

Courtesy: The Wire

Representational Image

Photo: The Indian Express

Pune Court Rejects Cutis' Suit Against Serum Institute Over "Covishield" Name

A Pune court has rejected Cutis Biotech’s claim seeking the Serum Institute of India to drop the use of trademark ‘Covishield’ for its COVID-19 vaccine. Rejecting Cutis’ application, the court observed that the company had approached it with "suppressed… read-more

Sun, 31 Jan 2021 - 12:35 AM / by Sakshi Teresa Emmanuel

Tags: Serum Institute of India, Cutis Biotech, COVISHIELD, lawsuit, trademark, civil court, High Court, Pune, Maharashtra

Courtesy: NDTV

Covid -19 Vaccine

Photo: Indian Express

SII Hopeful To Launch Its 2nd Vaccine 'COVOVAX' By June

The Serum Institute of India (SII) chief Adar Poonawalla on January 30 announced of hopefully launching ‘COVOVAX’ as the second COVID-19 vaccine in June 2021. Poonawalla also claimed that the Novavax vaccine that has partnered with the US is currently undergoing trials and has shown excellent efficiency. While DCGI approved vaccines Covishield and Covaxin were used in India, the COVOVAX would become the third vaccine developed by India if… read-more

Sat, 30 Jan 2021 - 07:48 PM / by Sakshi Teresa Emmanuel

Tags: Serum Institute of India, Adar Poonawalla, Covovax, Novavax, Coronavirus, Covid-19 Vaccine

Courtesy: Zee News

Novavax

Photo: Quartz

SII Awaits Govt Approval To Conduct Trials Of Novavax COVID Vaccine

The Serum Institute of India has applied to the Drugs Controller General of India seeking permission to conduct domestic trials of ‘Novavax’ coronavirus vaccine. Reportedly, the US-based company claimed that Novavax showed 89.3% and 60% effectiveness during the trials in the UK and Africa respectively. Earlier, Novavax and SII collaborated to produce 2 billion vaccine doses. Besides, Novavax has received around $388 million from the Coalition… read-more

Fri, 29 Jan 2021 - 01:19 PM / by Nikita Thakur

Tags: Novavax, SII, Serum Institute of India, DCGI

Courtesy: Live Mint

Fire At SII

Photo: DNA India

SII Announces Compensation Of Rs 25 Lakh To Families Of Deceased

Pune-based the Serum Institute of India has announced a Rs 25-lakh compensation to the families of five deceased who lost their lives in the fire outbreak on January 21. Expressing his grief, SII CEO Adar Poonawalla said, "Extremely sorrowful day for all of us". Reportedly, four other people were evacuated from the SII's Manjari premises . Meanwhile, the SII and Maharashtra CM Uddav Thackary have assured that the accident will not affect… read-more

Fri, 22 Jan 2021 - 06:50 AM / by Nikita Thakur

Tags: Serum Institute of India, SII, Fire at SII, Fire Outbreak, Pune

Courtesy: Times Now

Fire at SII's building in Manjari, Pune.

Photo: Republic World

Pune: Fire Breaks Out At New SII Campus At Manjari

Serum Institute of India's premises at Pune's Manjari witnessed a fire breakout in its new building on January 21. As per the fire brigade officials, 10 fire tenders have been deployed at the site, where the incident happened around 2:30 pm. However, officials confirmed that the affected building was "not directly connected to Covishield manufacturing". Meanwhile, the evacuation process is underway, and no casualties have been reported until… read-more

Thu, 21 Jan 2021 - 03:55 PM / by Harsh Vardhan

Tags: Serum Institute of India, Pune, Manjari, Covishield vaccine

Courtesy: The Indian Express

Representative image COVID-19 vaccines

Photo: Asianet Newsable

People May Not Have Option To Choose From COVID Vaccines, Hints Govt

Stating that no other country with two or more vaccines has given an option, the health ministry representative on January 12 hinted that India will not provide option to choose between COVID-19 vaccines. Addressing a press conference, Health Secretary Rajesh Bhushan said both the vaccines of India are equally safe and there is no risk. Reportedly, the government will procure 110 lakh doses from Serum Institute of India and 55 lakh doses from… read-more

Wed, 13 Jan 2021 - 12:04 PM / by Bhavyata Kagrana

Tags: Covid-19 Vaccine, Covaxin, Bharat biotech, Serum Institute of India

Courtesy: The Times of India

Covishield

Photo: The Financial Express

Govt Orders 11Mn Doses Of 'Covishield' At Rs 200/Dose From SII

Taking a step ahead towards the COVID-19 vaccination, the Centre has ordered the first set of 11 million doses of Serum Institute of India's 'Covishield' vaccine. Ordered at the cost of Rs 200 per dose, the doses are expected to vaccinate around 10 million frontline workers nation-wide. Reportedly, the Union will afford the vaccination cost for 30 million workers without charging the states. The government will roll-out the mass vaccination… read-more

Mon, 11 Jan 2021 - 06:42 PM / by Nikita Thakur

Tags: Serum Institute of India, COVISHIELD, Adar Poonawalla, Covid Vaccination

Courtesy: Hindustan Times